Clinical Trial Update: A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating two doses of the Shanchol oral cholera vaccine in people aged 1 year and older in the Dominican Republic has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Shanchol (oral cholera vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Cholera | Phase 3 | Status: COMPLETED